Sarepta Therapeutics

Sarepta rebuilds drug pipeline with Arrowhead deal
BioPharma Dive
Wed, 11/27/24 - 11:36 am
Sarepta Therapeutics
Arrowhead Pharmaceuticals
drug development
Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead
Fierce Biotech
Tue, 11/26/24 - 10:19 pm
Sarepta Therapeutics
Arrowhead Pharmaceuticals
Sarepta pulls plug on Duchenne exon-skipping drug
Pharmaphorum
Thu, 11/7/24 - 11:09 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
DMD
vesleteplirsen
Is anyone taking the world’s priciest drugs?
Pharma Voice
Fri, 08/30/24 - 11:28 am
drug prices
gene therapy
CRISPR Therapeutics
Vertex Pharmaceuticals
Sarepta Therapeutics
Sarepta Therapeutics falls on revenue miss, weak outlook
Investing.com
Wed, 08/7/24 - 11:07 pm
Sarepta Therapeutics
earnings
Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents
Fierce Pharma
Tue, 07/30/24 - 06:35 pm
Sarepta Therapeutics
Sanofi
legal
patents
Elevidys
DMD
After full approval, Sarepta lays out its next moves
BioSpace
Wed, 06/26/24 - 11:31 am
Sarepta Therapeutics
DMD
Elevidys
gene therapy
Sarepta Duchenne gene therapy wins broader use from FDA
BioPharma Dive
Thu, 06/20/24 - 06:09 pm
Sarepta Therapeutics
gene therapy
FDA
DMD
Elevidys
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive
Thu, 06/13/24 - 11:07 pm
Pfizer
DMD
gene therapy
FDA
Sarepta Therapeutics
Elevidys
Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapy
BioSpace
Wed, 05/8/24 - 11:13 am
Sarepta Therapeutics
DMD
Elevidys
gene therapy
FDA’s Accelerated Approval of Sarepta DMD Gene Therapy Comes Under Fire
BioSpace
Fri, 05/3/24 - 11:20 am
FDA
accelerated approvals
Sarepta Therapeutics
DMD
gene therapy
Regenxbio data suggest ‘niche’ in Duchenne gene therapy
BioPharma Dive
Thu, 03/7/24 - 11:05 am
Regenxbio
Duchenne Muscular Dystrophy
DMD
RGX-202
Sarepta Therapeutics
Elevidys
Sarepta’s Duchenne Gene Therapy Elevidys Nabs $200M on Strong Demand
BioSpace
Thu, 02/29/24 - 11:00 am
Sarepta Therapeutics
gene therapy
Elevidys
earnings
Duchenne Muscular Dystrophy
FDA to review Sarepta's Duchenne gene therapy for traditional approval
Reuters
Fri, 02/16/24 - 11:38 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
gene therapy
FDA
Elevidys
Sarepta's next DMD drug seems to get the job done, but Elevidys casts long shadow
Fierce Biotech
Mon, 01/29/24 - 10:25 pm
Sarepta Therapeutics
DMD
SRP-5051
Elevidys
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
Motley Fool
Thu, 01/25/24 - 11:01 am
Sarepta Therapeutics
Vertex Pharmaceuticals
Why Sarepta Therapeutics Stock Zoomed Nearly 5% Higher Today
Motley Fool
Mon, 01/22/24 - 10:13 pm
Sarepta Therapeutics
Elevidys
Sarepta begins screening in muscular dystrophy gene therapy trial
Clinical Trials Arena
Wed, 01/17/24 - 09:25 am
Sarepta Therapeutics
clinical trials
SRP-9003
limb-girdle muscular dystrophy
5 of the best paid biopharma CEOs
PharmaVoice
Mon, 11/13/23 - 10:10 am
Pharma CEOs
executive compensation
Sarepta Therapeutics
Royalty Pharma
Seagen
Zentalis
Pfizer
Sarepta enjoys early sales ramp for DMD gene therapy, maintains confidence in label expansion
Fierce Pharma
Thu, 11/2/23 - 05:15 pm
Sarepta Therapeutics
DMD
Duchenne Muscular Dystrophy
Elevidys
gene therapy

Pages